drugset / Trial / NCT00526097

Dulcolax vs Placebo in Functional Constipation

NCT00526097

Phase 3 Completed 368 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of the study was to compare the efficacy and safety of 4 weeks treatment with bisacodyl (Dulcolax) tablets 10 mg to placebo in patients with functional constipation. In addition, the effect of treatment on quality of life and general health status was evaluated.

Timeline

Start
2007-09
Primary completion
2009-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bisacodyl Small molecule 10 mg Oral

Indications